Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.48 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.48 |
| ▸ | ACR | P10323 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.44 |
| ▸ | RET | P07949 | 1/20 | 0.44 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.44 |
| ▸ | PIM1 | P11309 | 1/20 | 0.44 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.44 |
| ▸ | GSK3B | P49841 | 1/20 | 0.44 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.44 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1696565 | 0.80 | L3MBTL1 (0.63) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL2375495 | 0.77 | L3MBTL1 (0.59) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL4005632 | 0.77 | CYP2D6 (0.68) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL2522379 | 0.77 | LMNA (0.62) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL27677855 | 0.77 | LMNA (0.62) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL2523376 | 0.77 | LMNA (0.62) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL23773818 | 0.76 | L3MBTL1 (0.58) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL14985501 | 0.75 | TRPV3 (0.40) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL28171521 | 0.75 | CYP11B1 (0.66) | L3MBTL1LMNACYP11B1CYP11B2RAB9A | |
| SCHEMBL2375029 | 0.75 | L3MBTL1 (0.56) | L3MBTL1LMNACYP11B1CYP11B2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120225886-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | MERCK SHARP & DOHME, CORP. (US) | 2012-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120225886-A1 | NOVEL PYRROLIDINE DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS | ADRB3, ADRB1, ADRB2 | L3MBTL1 4267/4885LMNA 1824/4885CYP11B1 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.